<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Ai-Generated-Synthetic-Control-Arms on Bioecon</title><link>https://en.bioecon.ru/technologies/ai-generated-synthetic-control-arms/</link><description>Recent content in Ai-Generated-Synthetic-Control-Arms on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Mon, 20 Jul 2026 22:21:00 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/technologies/ai-generated-synthetic-control-arms/index.xml" rel="self" type="application/rss+xml"/><item><title>Patient digital twins &amp; in-silico trials</title><link>https://en.bioecon.ru/technology/patient-digital-twins-in-silico-trials/</link><pubDate>Mon, 20 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/patient-digital-twins-in-silico-trials/</guid><description>Computational patient models and virtual trial simulations used to reduce, accelerate or de-risk clinical development — AI-generated synthetic control arms, physiologically-based pharmacokinetic modeling, preclinical-to-clinical translation AI and causal-AI virtual patient simulation: Unlearn.AI, Certara and VeriSIM Life in the US, and Novadiscovery (Nova In Silico) in France.</description></item></channel></rss>